Therapeutic Area Strategy Head, CRM

Job Description Summary

#LI-Hybrid
Location: Cambridge, MA or East Hanover, NJ
Please note, this role can be based in the US or Basel, Switzerland. If you are based in Europe, please apply via REQ-10069554.

The Therapeutic Area Strategy Head will lead a therapeutic area focused team in the creation and ongoing update of a holistic and aligned Enterprise portfolio strategy for their Therapeutic Area (TA). The candidate will work closely with the senior leaders within the cardio-renal-metabolic (CRM) TA including Bio-medical Research (BR), Development and Commercial organizations in US and International and Search & Evaluation. The candidate will bring a passion for innovation, deep industry experience, scientific acumen and strong judgement to guide internal choices and drive sustainable growth in the short, mid and long-term in CRM. This individual will have both a broad and deep understanding of the CRM field to drive insightful and differentiating competitive advantages over our peers by bringing a third-party view around key strategic levers and external analyses, trends, and white space opportunities. Additionally, they will conduct targeted primary research.

 

Job Description

Key Responsibilities:

Provides external perspective and identifies opportunities:

• Builds and maintains in-depth knowledge of the TA (early pipeline to commercial); including disease models; responsible for ongoing assessment of peer companies with heavy exposure in the TA.

• Educates, updates and provides external views to all internal stakeholders.  Provides insight within key portfolio governance processes (diligence and external landscape mapping with BD&L and M&A)

• Supports identification of growth accretive opportunities, indications, disease spaces and rejection of low value opportunities/projects

• Supports Group Investor Relations and the CEO Office with dissemination of key strategic insights

• Ongoing collection and synthesis of scientific and commercial insights for the TA

Owns TA portfolio strategy and prioritization:

• Leads the process of creating, maintaining and updating enterprise-wide TA portfolio strategy, including disease area and molecule selection to drive mid- and long-term growth in collaboration with RDC

• Identifies potential pipeline gaps, makes recommendations to address

• Works closely with key stakeholders in the Therapeutic Area Leadership (TAL) team to facilitate portfolio decision making, prioritization and trade-offs

Internal and External Commercial and Pipeline Modelling:

• Oversees assessments of programs fit to current portfolio strategy and facilitates central review for assets inside and outside current priorities (e.g., at Innovation Management Board (IMB))

• Provides consolidated commercial and development inputs to support business cases for internal and external assets and programs

• Provides outside-in independent view of internal assumptions around core pipeline

• Leads the development of assessment of external opportunities (e.g., forecast assumptions, business cases)

Others:

• Coaches, attracts, develops, and retains top talents; partners with P&O leadership to develop people strategy (e.g. organization development, performance, career development).

• Plans, allocates, and manages TA strategy financial budget by anticipating expenditures, accurately forecasting resource needs/costs and properly accounting for expenses to meet requirements and achieve fiscal responsibility

Essential Requirements:

• Advanced degree or equivalent experience in life science/healthcare required, Cardiologist training highly desirable

• Demonstrated cross‑functional global leadership experience is essential.

• Minimum 10 years of pharmaceutical/biotech experience gained in banking, consulting, or biopharma, with exposure to drug development and ideally commercialization required. Proven ability to operate effectively in a highly matrixed, fast paced environment.

• Candidates with significant senior leadership experience — including Biotech CEOs and executives from investment banking or other Wall Street institutions are strongly preferred

• Ability to comfortably engage with the C-suite and mid-career associates to influence and challenge with excellent interpersonal and leadership skills

• Strong financial and business acumen with strong understanding of biopharma landscape; companies, assets and early technologies

• Strong strategic vision, superior leadership, excellent comm